Obsidian Therapeutics reported earnings of -$ 1.23 per OBX share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.52 |
| Earnings Per Share (Surprise) | -$ 1.23 (-$ 0.71) |
Out of the last 8 earnings reporting periods, Obsidian Therapeutics beat analysts’ expectations 5 times and fell short of expectations 3 time(s). Obsidian Therapeutics reported earnings per share of -$ 1.23 in the last report falling to reach an estimated EPS of -$ 0.52 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.52 | -$ 1.23 | -$ 66.00 | |
| Aug 28, 2026 | -$ 1.63 | -$ 1.38 | -$ 96.00 | |
| Mar 31, 2025 | -$ 60.00 | - | - | |
| Dec 13, 2024 | -$ 58.00 | - | - | |
| Aug 14, 2024 | $ 165.45 | -$ 14.00 | - | - |
| May 13, 2024 | -$ 58.89 | -$ 16.00 | - | - |
| Nov 14, 2023 | -$ 79.44 | -$ 66.00 | - | - |
| Aug 14, 2023 | -$ 75.66 | -$ 96.00 | - | - |
Obsidian Therapeutics’s stock was trading at $ 12.88 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, OBX’s price decreased to $ 12.56 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 1.23 | $ 12.88 | $ 12.56 | |
| Aug 28, 2026 | -$ 1.38 | $ 17.04 | $ 17.51 |
Obsidian Therapeutics released its most recent earnings reports in November 2026, August 2026, March 2025, December 2024 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Obsidian Therapeutics missed analysts’ expectations during the last earnings period by
